Drug Shortage Report for S.O.S. NALOXONE HYDROCHLORIDE INJECTION

Last updated on 2019-07-03 History
Report ID 80576
Drug Identification Number 02453258
Brand name S.O.S. NALOXONE HYDROCHLORIDE INJECTION
Common or Proper name NALOXONE HCl Inj SOS
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) NALOXONE HYDROCHLORIDE
Strength(s) 0.4MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10X1ml
ATC code V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2019-05-10
Actual start date 2019-05-03
Estimated end date 2019-07-01
Actual end date 2019-07-01
Shortage status Resolved
Updated date 2019-07-03
Company comments Limited inventory is currently available for this product at Sandoz. To maintain our inventory levels and to avoid unanticipated bulk orders, the product will be placed on protective allocation at 100% of historical monthly volumes staring April 16th 2019 until return date.
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2019-07-03 French Compare
v15 2019-07-03 English Compare
v14 2019-05-07 French Compare
v13 2019-05-07 English Compare
v12 2019-05-07 French Compare
v11 2019-05-07 English Compare
v10 2019-04-17 French Compare
v9 2019-04-17 English Compare
v8 2019-04-17 French Compare
v7 2019-04-17 English Compare
v6 2019-04-17 English Compare
v5 2019-04-12 French Compare
v4 2019-04-12 English Compare
v3 2019-04-06 English Compare
v2 2019-04-05 French Compare
v1 2019-04-05 English Compare

Showing 1 to 16 of 16